Alpha Mark Advisors, LLC Alkermes Plc. Transaction History
Alpha Mark Advisors, LLC
- $290 Million
- Q3 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 12,266 shares of ALKS stock, worth $363,686. This represents 0.12% of its overall portfolio holdings.
Number of Shares
12,266
Previous 12,781
4.03%
Holding current value
$363,686
Previous $308,000
11.36%
% of portfolio
0.12%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$863 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$563 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$385 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$375 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$272 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.87B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...